Thus, we examined the effect of SRC inhibition in the previously defined in vitro functional activity induced by P-cadherin expression, by treating cells with 100 nM of dasatinib (concentration that does not affect the metabolic state and viability of breast cancer cells – Additional file 1: Figure S1D). This evidence concerns the gene SRC and breast carcinoma.